Literature DB >> 31971155

Authors' Response.

Hardeep Singh Malhotra1, Ravindra Kumar Garg1, Ravi Shekhar Jaipuriar1, Imran Rizvi1, Neeraj Kumar1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31971155      PMCID: PMC6838592          DOI: 10.4269/ajtmh.19-0535b

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
Dear Sir, We thank the author for his comments on the immune status in patients with tuberculous meningitis.[1] We agree that being tested negative for HIV infection does not mean that there is a perfect state of immunocompetence.[2] We believe that immune dysregulation in any form, primary or secondary, can alter the course of tuberculous meningitis and affect its outcome. In view of the paucity of literature in this area, we are currently studying the prevalence of primary immunodeficiencies in patients with tuberculous meningitis, after having ruled out the commoner secondary immunodeficiencies in addition to HIV infection, including hepatitis C virus and hepatitis B virus infections, diabetes mellitus, and hepatic dysfunction.[3,4] We are evaluating humoral (antibody and complement aberrancies) as well as cellular (T-cell and B-cell disorders) immune dysfunction. We expect that these studies will add to our understanding of immunodeficiency and tuberculous meningitis.
  3 in total

1.  Changes in cerebrospinal fluid cytokine expression in tuberculous meningitis patients with treatment.

Authors:  Rajpal S Kashyap; Poonam S Deshpande; Sonali R Ramteke; Milind S Panchbhai; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Neuroimmunomodulation       Date:  2010-04-17       Impact factor: 2.492

2.  Early Mortality among Immunocompetent Patients of Tuberculous Meningitis: A Prospective Study.

Authors:  Ravi Shekhar Jaipuriar; Ravindra Kumar Garg; Imran Rizvi; Hardeep Singh Malhotra; Neeraj Kumar; Amita Jain; Rajesh Verma; Praveen Kumar Sharma; Shweta Pandey; Ravi Uniyal
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

3.  Cerebrospinal fluid cytokines in patients with tuberculous meningitis.

Authors:  C M Mastroianni; F Paoletti; M Lichtner; C D'Agostino; V Vullo; S Delia
Journal:  Clin Immunol Immunopathol       Date:  1997-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.